Auro Laboratories P/E Ratio
Current P/E Ratio
79.83
High Valuation
Very High - High growth expectations or significantly overvalued
Auro Laboratories (AUROLAB) P/E ratio is 79.83 (High), EPS (TTM) ₹5.67, current price ₹233.65 on BSE — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Auro Laboratories stock price NSE.
Current Valuation Metrics
P/E Ratio
79.83
Current Price
₹233.65
EPS (TTM)
₹5.67
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
54.32
Sector Median
30.97
Sector Rank
#11 of 198
Sector Percentile
5.6%
Earnings Breakdown (TTM)
TTM EPS
₹2.76
Sept 2025
₹1.15
Jun 2025
₹-0.17
AUROLAB P/E Ratio — Valuation Signal & Historical Context
Auro Laboratories P/E 79.83 — signal: Overvalued. Compare with AUROLAB fair value estimate to assess whether the stock is under or overvalued.
- Stock appears overvalued with PE of 79.83, suggesting caution for new investments
- Trading at premium to sector average PE of 54.32
AUROLAB vs Healthcare Peers — P/E Ratio Comparison
Auro Laboratories P/E 79.83 vs Healthcare average 54.32, median 30.97 — range 2.86–706.0.
Sector Average
54.32
Sector Median
30.97
Lowest P/E
2.86
Highest P/E
706.0
Companies
198
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 2.98 | ₹52 | Low |
| Colinz Laboratories | COLINZ | 3.34 | ₹10 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,329 | Low |
| Sunrest Lifescience | SUNREST | 4.19 | ₹67 | Low |
| Shelter Pharma | SHELTER | 4.99 | ₹46 | Low |
| GKB Ophthalmics | GKB | 5.81 | ₹32 | Low |
| JFL Life Sciences | JFLLIFE | 5.83 | ₹78 | Low |
| Dipna Pharmachem | DPL | 5.9 | ₹14 | Low |
| Royal Sense | ROYAL | 6.73 | ₹48 | Low |